For Your Frontotemporal Dementia Study, You’ll Want the Experience of Worldwide Clinical Trials on Your Side

Frontotemporal dementia (FTD) is characterized by progressive loss of nerve cells in the frontal and/or temporal lobes of the brain. Symptoms of FTD are typically associated with changes in behavior and impairment of language skills. While much has been learned in the past two decades about the characteristics and biology of FTD, there is still no known cure for the disorder, and current treatments only address the mood-related aspects of the condition.

When engaging CRO services for neurological indications, you need the broad knowledge base Worldwide Clinical Trials brings to the table. From our earliest studies in dementia-related conditions, we have established ourselves as a world leader in neurological research. Combining the unparalleled expertise of our study team with solid investigative site relationships helps us ensure that your dementia study is designed strategically and executed precisely to achieve your goals.